Metabasis Therapeutics News - MBRX

Best deals to access real time data!
CHART Trader
Monthly Subscription
for only
Canadian Level 1 + USA
Monthly Subscription
for only
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type ISIN Company Description
Metabasis Therapeutics MBRX NASDAQ Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  0.055 4.40% 1.31 1.34 1.25 1.27 1.25 14:07:50
more quote information »

Recent News

Date Time Source Heading
6/20/20198:56IHNWPromotedPlant and CBD sector Stocks to research and own that are defying the odds:
5/31/201916:09EDGARCurrent Report Filing (8-k)
5/24/201917:02EDGARStatement of Changes in Beneficial Ownership (4)
5/24/201917:02EDGARStatement of Changes in Beneficial Ownership (4)
5/24/201916:11EDGARCurrent Report Filing (8-k)
5/14/201907:32EDGARCurrent Report Filing (8-k)
5/14/201907:30PRNUSMoleculin Biotech, Inc. Reports Financial Results for the..
5/13/201916:04EDGARQuarterly Report (10-q)
5/07/201916:37EDGARCurrent Report Filing (8-k)
5/07/201907:30PRNUSMoleculin Announces Additional Positive Interim Results in..
5/03/201912:50EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
5/02/201911:48EDGARStatement of Ownership (sc 13g)
4/29/201916:12EDGARCurrent Report Filing (8-k)
4/29/201909:00PRNUSGenerex Biotechnology Announces Organizational Roadmap &..
4/29/201908:00PRNCAPositive Results From HMN Lithium Project P.E.A.
4/29/201907:00PRNUSUS Biopharma Company Undertakes Anti-Cancer Clinical Trials..
4/24/201906:03EDGARCurrent Report Filing (8-k)
4/24/201906:02EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
4/23/201913:31EDGARStatement of Ownership (sc 13g)
4/23/201908:40PRNUSMoleculin Announces $15.0 Million Registered Direct Offering
4/22/201907:30PRNUSMoleculin Announces Conference Call to Discuss Significant..
4/18/201907:30PRNUSMoleculin Receives FDA Approval of Fast Track Designation..
4/17/201907:30PRNUSMoleculin Announces Significant Discovery in Lung Cancer..
4/16/201916:13EDGARProxy Statement (definitive) (def 14a)
4/12/201916:06EDGARProxy Soliciting Materials (revised) (prer14a)
4/11/201916:12EDGARCurrent Report Filing (8-k)
4/11/201907:30PRNUSMoleculin Announces Agreement with Emory University to..
4/09/201907:30PRNUSMoleculin Announces Successful Expansion of its Leukemia..
4/08/201917:25EDGARStatement of Ownership (sc 13g)
4/05/201917:29EDGARProxy Statement - Notice of Shareholders Meeting..
4/03/201907:30PRNUSMoleculin Announces Preclinical Pancreatic Cancer Data..
4/01/201903:10PRNCAEnerCube Completes Complex Design Project With Altasteel
3/29/201906:04EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
3/28/201906:19EDGARCurrent Report Filing (8-k)
3/27/201909:05PRNUSMoleculin Announces Pricing Of Underwritten Public Offering
3/26/201917:37PRNUSMoleculin Announces Proposed Underwritten Public Offering
3/26/201917:26EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
3/26/201907:33EDGARCurrent Report Filing (8-k)
3/26/201907:30PRNUSMoleculin Announces Positive Interim Results in First Cohort..
3/19/201907:30PRNUSMoleculin Announces First Patients Enrolled in Lymphoma..
3/18/201916:05PRNUSMoleculin Announces Memorial Sloan Kettering Chief of..
3/18/201916:02EDGARCurrent Report Filing (8-k)
3/18/201907:30PRNUSMoleculin Biotech, Inc. to Present at the Oppenheimer 29th..
3/14/201916:23EDGARCurrent Report Filing (8-k)
2/21/201916:59GLOBEMoleculin Biotech, Inc. Reports Financial Results for the..
2/21/201916:35EDGARCurrent Report Filing (8-k)
2/21/201916:34EDGARAnnual Report (10-k)
2/20/201907:30GLOBEMoleculin Announces Outlicensing Deal To Accelerate..
2/19/201903:05PRNCANorthern Lights Supply Store in Alberta Receives First..
2/14/201907:30PRNCAPremier Health Provides Corporate Update
2/07/201916:03EDGARCurrent Report Filing (8-k)
See more news about this stock »

Your Recent History
Metabasis ..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.